First author, year, reference | Marker | Study type | Study population | Key findings | Limitations |
---|---|---|---|---|---|
Ramakrishna et al., 2012, [107] | Lactate | Single-center, observational prospective cohort-study (follow-up until hospital discharge) | 233 Malawian children with pneumonia | - The odds ratio for in-hospital mortality (25 deaths) in children with lactate >2 mmol/L was 7.48 (95 % CI 1.72–32.6) compared with children with lactate <2 mmol/L | - Single-center study |
- Low statistical power (only 25 deaths) | |||||
Chen et al., 2015, [108] | Lactate | Single-center, observational prospective cohort-study (28-day follow-up) | 1,641 patients with pneumonia (861 inpatients, 780 outpatients) (Emergency Department of Beijing Chao-Yang Hospital) | - Non-survivors had higher lactate and CURB-65 scores compared with survivors (p < 0.001) | - Single-center study |
- No information about microorganisms | |||||
- Lactate predicted 28-day mortality better than CURB-65 score (AUC 0.823 vs. 0.692; p < 0.01) | |||||
- Combination of lactate and CURB-65 score improved the predictive value of CURB-65 score alone (AUC 0.851) |